Delving into the Latest Updates on Florastamin[18F] with Synapse

Overview

Basic Info

Drug Type

Small molecule drug, Diagnostic radiopharmaceuticals

Synonyms-

Target

PSMA

Action-

Mechanism

PSMA inhibitors(Prostate-specific membrane antigen inhibitors)

Therapeutic Areas

NeoplasmsUrogenital Diseases

Active Indication

PSMA-Positive Prostatic Cancer

Inactive Indication-

Originator Organization

HTA Co., Ltd.

Active Organization

HTA Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

In this study, 18F-Florastamin PET/CT will be performed in patients with at least intermediate risk prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.
This study will first carry out the pilot study (including pharmacokinetics and radiation dosimetry).

Start Date20 Oct 2023

Sponsor / Collaborator

HTA Co., Ltd.

KCT0009634

/ RecruitingNot ApplicableIIT

The Clinical Efficacy of [F-18]Florastamin PET/CT for Initial Staging and Relapsed Restaging in Prostate Cancer: A Single-Center Prospective Pilot Study

Start Date16 Oct 2023

Sponsor / Collaborator-

CTR20233678

/ RecruitingPhase 3

一项评价氟[18F]司他明注射液PET/CT成像在至少中危前列腺癌患者中的诊断效能及安全性的开放性、多中心III期临床研究

[Translation] An open-label, multicenter phase III clinical study to evaluate the diagnostic efficacy and safety of 18F-fluoro[18F]sitamin injection PET/CT imaging in patients with at least intermediate-risk prostate cancer

在受试者水平，评估氟[18F]司他明注射液PET/CT成像检测盆腔淋巴结转移的特异度。

[Translation]

To evaluate the specificity of 18F-fluoro[18F]setamin injection PET/CT imaging for detecting pelvic lymph node metastasis at the subject level.

Start Date13 Sep 2023

Sponsor / Collaborator

HTA Co., Ltd.

100 Clinical Results associated with Florastamin[18F]

Login to view more data

100 Translational Medicine associated with Florastamin[18F]

Login to view more data

100 Patents (Medical) associated with Florastamin[18F]

Login to view more data

100 Deals associated with Florastamin[18F]

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
PSMA-Positive Prostatic Cancer	Phase 3	China	HTA Co., Ltd.	13 Sep 2023

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


AUA2022	Not Applicable	Prostatic Cancer	82	[F-18]FLORASTAMINR ([F-18] FlorastaminR PET/CT)	zquehqouib(bohjjbuevo) = mhsdoaqtzv dqkclwytdz (islwnbvhuc ) View more	-	01 May 2022
				[F-18]FLORASTAMINR (Multi-parametric magnetic resonance imaging (mpMRI))	zquehqouib(bohjjbuevo) = pehgxdzxss dqkclwytdz (islwnbvhuc ) View more